BioLife Solutions Price to Sales Ratio 2010-2024 | BLFS
Historical PS ratio values for BioLife Solutions (BLFS) over the last 10 years. The current P/S ratio for BioLife Solutions as of November 13, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| BioLife Solutions P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-12 | 26.50 | 8.65 | |
| 2024-06-30 | 21.43 | $3.06 | 7.00 |
| 2024-03-31 | 18.55 | $3.12 | 5.95 |
| 2023-12-31 | 16.25 | $3.30 | 4.93 |
| 2023-09-30 | 13.81 | $3.36 | 4.11 |
| 2023-06-30 | 22.10 | $3.55 | 6.23 |
| 2023-03-31 | 21.75 | $3.83 | 5.68 |
| 2022-12-31 | 18.20 | $3.81 | 4.77 |
| 2022-09-30 | 22.75 | $3.74 | 6.08 |
| 2022-06-30 | 13.81 | $3.57 | 3.87 |
| 2022-03-31 | 22.73 | $3.38 | 6.72 |
| 2021-12-31 | 37.27 | $3.03 | 12.30 |
| 2021-09-30 | 42.32 | $2.60 | 16.28 |
| 2021-06-30 | 44.51 | $2.18 | 20.46 |
| 2021-03-31 | 36.00 | $1.83 | 19.69 |
| 2020-12-31 | 39.89 | $1.90 | 20.99 |
| 2020-09-30 | 28.94 | $1.79 | 16.19 |
| 2020-06-30 | 16.35 | $1.69 | 9.67 |
| 2020-03-31 | 9.50 | $1.54 | 6.17 |
| 2019-12-31 | 16.18 | $1.30 | 12.49 |
| 2019-09-30 | 16.63 | $1.09 | 15.21 |
| 2019-06-30 | 16.95 | $1.09 | 15.60 |
| 2018-12-31 | 12.03 | $1.08 | 11.10 |
| 2018-09-30 | 17.50 | $0.98 | 17.77 |
| 2018-06-30 | 11.41 | $1.07 | 10.66 |
| 2018-03-31 | 5.13 | $1.04 | 4.93 |
| 2017-12-31 | 6.00 | $0.96 | 6.22 |
| 2019-03-31 | 17.89 | $0.91 | 19.64 |
| 2017-09-30 | 5.71 | $0.78 | 7.32 |
| 2017-06-30 | 2.39 | $0.72 | 3.30 |
| 2017-03-31 | 2.09 | $0.69 | 3.04 |
| 2016-12-31 | 1.61 | $0.65 | 2.47 |
| 2016-09-30 | 1.84 | $0.62 | 2.95 |
| 2016-06-30 | 1.60 | $0.59 | 2.71 |
| 2016-03-31 | 1.83 | $0.56 | 3.29 |
| 2015-12-31 | 2.17 | $0.53 | 4.09 |
| 2015-09-30 | 2.11 | $0.54 | 3.90 |
| 2015-06-30 | 1.95 | $0.51 | 3.82 |
| 2015-03-31 | 1.61 | $0.49 | 3.30 |
| 2014-12-31 | 1.64 | $0.73 | 2.23 |
| 2014-09-30 | 2.10 | $1.03 | 2.03 |
| 2014-06-30 | 2.28 | $1.36 | 1.67 |
| 2014-03-31 | 3.69 | $1.73 | 2.14 |
| 2013-12-31 | 8.40 | $1.79 | 4.70 |
| 2013-09-30 | 11.20 | $1.74 | 6.42 |
| 2013-06-30 | 5.04 | $1.65 | 3.06 |
| 2013-03-31 | 4.06 | $1.40 | 2.89 |
| 2012-12-31 | 4.76 | $1.14 | 4.18 |
| 2012-09-30 | 1.82 | $0.89 | 2.05 |
| 2012-06-30 | 1.26 | $0.70 | 1.81 |
| 2012-03-31 | 1.40 | $0.60 | 2.33 |
| 2011-12-31 | 0.70 | $0.55 | 1.26 |
| 2011-09-30 | 1.12 | $0.51 | 2.21 |
| 2011-06-30 | 1.12 | $0.47 | 2.39 |
| 2011-03-31 | 1.12 | $0.44 | 2.56 |
| 2010-12-31 | 0.84 | $0.42 | 2.01 |
| 2010-09-30 | 1.26 | $0.40 | 3.16 |
| 2010-06-30 | 1.40 | $0.38 | 3.65 |
| 2010-03-31 | 1.40 | $0.35 | 4.05 |
| 2009-12-31 | 1.54 | $0.32 | 4.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.223B | $0.143B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $201.960B | 25.76 |
| Stryker (SYK) | United States | $147.572B | 33.26 |
| Boston Scientific (BSX) | United States | $130.758B | 37.59 |
| Medtronic (MDT) | Ireland | $113.242B | 16.85 |
| EssilorLuxottica (ESLOY) | France | $110.003B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.726B | 0.00 |
| Haleon (HLN) | United Kingdom | $42.008B | 27.29 |
| GE HealthCare Technologies (GEHC) | United States | $38.798B | 20.12 |
| ResMed (RMD) | United States | $36.289B | 29.82 |
| Terumo (TRUMY) | Japan | $29.859B | 42.17 |
| Koninklijke Philips (PHG) | Netherlands | $24.401B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.886B | 13.93 |
| Insulet (PODD) | United States | $19.297B | 76.84 |
| Baxter (BAX) | United States | $17.259B | 11.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.746B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.206B | 34.68 |
| BellRing Brands (BRBR) | United States | $9.277B | 39.22 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.920B | 13.76 |
| TG Therapeutics (TGTX) | United States | $4.812B | 0.00 |
| Haemonetics (HAE) | United States | $4.690B | 22.89 |
| ICU Medical (ICUI) | United States | $4.348B | 41.49 |
| Prestige Consumer Healthcare (PBH) | United States | $4.033B | 20.06 |
| Perrigo (PRGO) | Ireland | $3.598B | 10.59 |
| Envista Holdings (NVST) | United States | $3.531B | 26.31 |
| Agios Pharmaceuticals (AGIO) | United States | $3.366B | 0.00 |
| Neogen (NEOG) | United States | $3.324B | 38.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.961B | 18.99 |
| QuidelOrtho (QDEL) | United States | $2.767B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $2.322B | 56.43 |
| Warby Parker (WRBY) | United States | $2.158B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.894B | 33.15 |
| AtriCure (ATRC) | United States | $1.786B | 0.00 |
| InMode (INMD) | Israel | $1.618B | 9.73 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.438B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 10.28 |
| Curaleaf Holdings (CURLF) | Canada | $1.326B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.015B | 17.90 |
| Owens & Minor (OMI) | United States | $0.997B | 7.79 |
| CeriBell (CBLL) | United States | $0.981B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.889B | 29.71 |
| Capricor Therapeutics (CAPR) | United States | $0.822B | 0.00 |
| Evolus (EOLS) | United States | $0.788B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.678B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.615B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.585B | 17.67 |
| Quanterix (QTRX) | United States | $0.582B | 0.00 |
| Surmodics (SRDX) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.389B | 0.00 |
| ZimVie (ZIMV) | United States | $0.389B | 32.74 |
| Canopy Growth (CGC) | Canada | $0.370B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.366B | 34.81 |
| Cerus (CERS) | United States | $0.351B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.309B | 20.70 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| Biote (BTMD) | United States | $0.299B | 6.57 |
| Zynex (ZYXI) | United States | $0.273B | 57.13 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Omeros (OMER) | United States | $0.247B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 16.01 |
| Jin Medical (ZJYL) | China | $0.223B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 89.67 |
| Organigram Holdings (OGI) | Canada | $0.173B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 97.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.96 |
| Zevia PBC (ZVIA) | United States | $0.152B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.136B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 11.03 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
| Rockwell Medical (RMTI) | United States | $0.088B | 47.17 |
| Cellectar Biosciences (CLRB) | United States | $0.087B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.69 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| MariMed (MRMD) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Exagen (XGN) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.046B | 0.00 |
| ImmuCell (ICCC) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.60 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |